The use of alternative medical therapies in patients with systemic lupus erythematosus
✍ Scribed by Andrew D. Moore; Michelle A. Petri; Susan Manzi; David A. Isenberg; Caroline Gordon; Jean-Luc Senécal; Yvan St. Pierre; Lawrence Joseph; John Penrod; Paul R. Fortin; Nurhan Sutcliffe; Jean Richard Goulet; Denis Choquette; Tamara Grodzicky; John M. Esdaile; Ann E. Clarke
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 118 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To evaluate the rate of thromboxane biosynthesis in patients with systemic lupus erythematosus (SLE), exploring the interplay between antiphospholipid antibodies (aPL) and 2 markers of endothelial perturbation: thrombin generation and platelet activation. Methods. A comparison of 11-dehydrothrombox
## Abstract ## Objective To determine whether quality of life in patients with systemic lupus erythematosus (SLE) measured by the Short Form 36 (SF‐36) changes over time and which patient‐ and disease‐related factors influence such change. ## Methods SLE patients who had ≥6 SF‐36 evaluations dur